Home/Cell Technologies/Katina Loucaides

KL

Katina Loucaides

Director

Cell Technologies

Therapeutic Areas

Osteoarthritis Degenerative Disc Disease

Cell Technologies Pipeline

Drug	Indication	Phase
ChondroStem™ Autologous	Knee and Hip Osteoarthritis	Phase 3
ChondroStem™ Allogeneic	Lumbar Degenerative Disc Disease	Phase 2/3

Leadership Team at Cell Technologies

Riam Shammaa, MD

President and Director

Sheona Docksteader

Corporate Secretary

View full Cell Technologies profile